ArticleAnnals of surgery2005

Neoadjuvant selective COX-2 inhibition down-regulates important oncogenic pathways in patients with esophageal adenocarcinoma.

Jurriaan B Tuynman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.